SCHEMBL30289293

SCHEMBL30289293

CN(CCNC(=O)OC(C)(C)C)C[Si](C)(C)C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.46
NPSR1 Q6W5P4 1/20 0.45
MEN1 O00255 1/20 0.44
GAA P10253 1/20 0.44
KMT2A Q03164 1/20 0.44
ALDH1A1 P00352 3/20 0.44
GFER P55789 1/20 0.44
CKS1B P61024 1/20 0.43
SKP1 P63208 1/20 0.43
SKP2 Q13309 1/20 0.43
HTT P42858 1/20 0.42
MAOA P21397 1/20 0.41
MAOB P27338 1/20 0.41
KDM4E B2RXH2 1/20 0.40
LMNA P02545 1/20 0.40
CA12 O43570 3/20 0.39
CA1 P00915 3/20 0.39
CA2 P00918 2/20 0.39
CA9 Q16790 2/20 0.39
EPHX1 P07099 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13055395 0.86 TDP1 (0.55) TDP1NPSR1MEN1GAAKMT2A
SCHEMBL25531030 0.81 TDP1 (0.50) TDP1NPSR1MEN1GAAKMT2A
SCHEMBL17209068 0.80 TDP1 (0.49) TDP1NPSR1MEN1GAAKMT2A
SCHEMBL5327354 0.80 TDP1 (0.57) TDP1NPSR1MEN1GAAKMT2A
SCHEMBL14877947 0.80 CA12 (0.49) TDP1NPSR1MEN1GAAKMT2A
SCHEMBL1979026 0.79 TDP1 (0.55) TDP1NPSR1MEN1GAAKMT2A
SCHEMBL18478942 0.79 TDP1 (0.47) TDP1NPSR1MEN1GAAKMT2A
SCHEMBL8286297 0.79 TDP1 (0.47) TDP1NPSR1MEN1GAAKMT2A
SCHEMBL1404486 0.79 MEN1 (0.49) TDP1NPSR1MEN1GAAKMT2A
SCHEMBL1584879 0.79 TDP1 (0.47) TDP1NPSR1MEN1GAAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4405359-A2 MDM2 DEGRADERS AND USES THEREOF Kymera Therapeutics, Inc. (US) 2024-07-31 EP disclosed
WO-2023049790-A2 MDM2 DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2023-03-30 WO disclosed